James Passin, CEO+1 646 452 7054
Media Contacts BioVaxys Technology Corp.
Gina Cestari, Senior VP 6 Degrees Public Relations+1 917 797 7904gcestari@6degreespr.com
View original content to download multimedia: https://www.prnewswire.com/news-releases/biovaxys-prepares-for-groundbreaking-study-on-reduced-ace2-binding-capabilities-of-hapten-modified-sars-cov-2-proteins-301383613.html
SOURCE BioVaxys Technology Corp.
View original content to download multimedia: http://www.newswire.ca/en/releases/archive/September2021/23/c4873.html
SOURCE: BioVaxys Technology Corp.
COMTEX_393855539/2197/2021-09-23T03:00:00
Is there a problem with this press release? Contact the source provider Comtex at editorial@comtex.com. You can also contact MarketWatch Customer Service via our Customer Center.
Copyright (C) 2021 CNW Group. All rights reserved.
